When Hard Data Are Sparse, FDA Looks To The Experts

Given the small dataset supporting the Arzerra BLA, FDA made up for the lack of solid data with exhaustive analysis and plentiful expert consultation

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet